11th Annual BioPartnering North America™ |
|||
|
BioPartnering North America (BPN) is expanding, to meet new needs, which reflect the changing world realities. It represents a cutting-edge solution to the major problem faced by busy executives: "Who should I meet with today?" Business opportunities and strategic partnerships exist for pharma, investors, and emerging biotech companies - this is what BPN helps life science companies do. BPN is a focused event for serious dealmakers! |
|
||
15th Annual C21 BioVentures™ |
|||
|
Information Coming Soon! C21 BioVentures (C21) is the leading conference where early stage innovators, investors and pharma partners come together to get deals done. With a focus on private companies seeking investors and pharma partners, C21 provides the best early stage opportunities for partnering. |
|
||
4th Annual BioPartnering Latin America™ |
|||
|
September 10 - 12, 2013 BioPartnering Latin America (BPL) 2012 housed over 270 participants from 157 companies and 15 countries! BPL fostered a productive networking atmosphere with 297 meetings scheduled through biopartnering.com. Between the packed sessions, busy meeting schedules and key leadership in attendance it is clear that Latin America's life science industry is ready for significant growth, investment and global partnerships. Join us in 2013! |
|
||
21th Annual BioPartnering Future Europe™ |
|||
|
|
|
||
AusBiotech 2013 National Conference |
|||
|
The AusBiotech national conference attracts senior people from across the sector as well as investors and business development professionals. The attendance of prominent biotech individuals, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. |
|
||
BioPartnering India™ at Bangalore India Bio |
|||
|
BioPartnering India (BPI) is based on a strong collaboration with India's most important life science conference: Bangalore India Bio. These combined events provide an important platform for global business development. Many Big Pharma players are already developing strategic alliances and collaborative research programs with Indian partners and that trend is set to continue. |
|
||









